Benefits of SGLT2 inhibitors in arrhythmias
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.1011429
Abstract: Some studies have shown that sodium-glucose cotransporter (SGLT) 2 inhibitors can definitively attenuate the occurrence of cardiovascular diseases such as heart failure (HF), dilated cardiomyopathy (DCM), and myocardial infarction. With the development of research, SGLT2… read more here.
Keywords: sglt2; inhibitors arrhythmias; role; benefits sglt2 ... See more keywords